Valirx (VAL) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Jul 2008 02:23 PM
RNS
Director/PDMR Shareholding
14 Jul 2008 07:00 AM
RNS
ValiRx acquires Cronos Therap
09 Jul 2008 07:00 AM
RNS
ValiRx Acquires Global Rights
30 Jun 2008 04:38 PM
RNS
Joint Broker Appointment
30 Jun 2008 07:00 AM
RNS
Final Results
26 Jun 2008 07:00 AM
RNS
Therapeutic Pipeline - in viv
23 Jun 2008 08:00 AM
RNS
Notice of Results
05 Jun 2008 09:13 AM
RNS
Holding(s) in Company
30 May 2008 07:00 AM
RNS
Total Voting Rights
28 May 2008 07:00 AM
PRN
Second Australian GeneICE Patent Granted
15 May 2008 12:37 PM
RNS
Holding(s) in Company
12 May 2008 04:42 PM
PRN
Statement re Placing of Shares
08 May 2008 08:05 AM
RNS
Issue of Equity
07 May 2008 02:20 PM
RNS
Holding(s) in Company
02 May 2008 11:35 AM
RNS
Result of EGM
30 Apr 2008 07:00 AM
RNS
Total Voting Rights
07 Apr 2008 05:13 PM
RNS
Notice of EGM and Placing
18 Mar 2008 07:50 AM
PRN
Valibio Research Update
13 Feb 2008 07:55 AM
PRN
Letter of Intent
29 Jan 2008 07:00 AM
PRN
Australian GeneICE Patent Granted
23 Jan 2008 07:00 AM
PRN
Morphogenesis Update
17 Jan 2008 07:00 AM
PRN
GeneICE – CRT Research Update
31 Dec 2007 07:00 AM
RNS
Total Voting Rights
12 Dec 2007 08:31 AM
PRN
Physiomics Collaboration Update
11 Dec 2007 07:00 AM
PRN
ValiBIO Update
27 Nov 2007 09:27 AM
PRN
Issue of Equity
12 Nov 2007 07:00 AM
PRN
European Technology Patent for Nucleosomics
25 Oct 2007 04:00 PM
PRN
Directorate Change
15 Oct 2007 07:00 AM
PRN
License Agreement
28 Sep 2007 10:00 AM
PRN
Interim Report
28 Sep 2007 07:01 AM
RNS
Total Voting Rights
26 Sep 2007 03:31 PM
RNS
Issue of Equity
21 Sep 2007 04:09 PM
RNS
Placing
10 Sep 2007 07:00 AM
PRN
GeneICE CRT update
17 Aug 2007 06:07 PM
RNS
AIM Rule 26 Information
08 Aug 2007 07:00 AM
PRN
European GeneICE Patent Granted and CRT Trials ...
31 Jul 2007 04:10 PM
RNS
Total Voting Rights
27 Jul 2007 10:27 AM
RNS
Result of AGM
19 Jul 2007 07:00 AM
PRN
Joint Venture
18 Jul 2007 02:16 PM
RNS
Issue of Equity
25 Jun 2007 02:00 PM
PRN
Final Results
12 Jun 2007 12:00 PM
PRN
ValiRx partners with Clarity Imaging
29 May 2007 01:00 PM
PRN
Strategic Alliance
14 May 2007 07:00 AM
PRN
CRT / Cronos agreement extension
26 Apr 2007 07:00 AM
PRN
US GeneICE Patent Granted
18 Apr 2007 07:00 AM
PRN
Research & Development Update
04 Apr 2007 07:00 AM
PRN
University of Surrey - Collaborative Agreement
27 Mar 2007 03:45 PM
RNS
Change of address
15 Feb 2007 07:00 AM
PRN
Physiomics plc - Agreement
09 Jan 2007 12:10 PM
PRN
Appointment of Non-Executive Director

ValiRx PLC: A Biotech Innovator on the London Stock Exchange (LSE)

ValiRx PLC, known by its ticker symbol VAL, is a trailblazer in the biotechnology sector. Its performance on the London Stock Exchange (LSE) has been remarkable, with the ValiRx share price reflecting the company's consistent growth and success.

As a member of the LSE, ValiRx PLC aligns with the London Stock Exchange Group's (LSEG) mission of supporting innovative and growing businesses. The LSEG recognises ValiRx PLC as a significant player, contributing to the robust and diverse ecosystem of the LSE.

The ValiRx share price on the LSE not only underscores its financial stability but also its strategic vision in the biotechnology industry. ValiRx PLC's journey on the LSE is a testament to its robust business model and its ability to create value for its stakeholders.

In conclusion, ValiRx PLC's association with the LSE and LSEG symbolises its commitment to growth, innovation, and value creation. As ValiRx PLC continues to thrive on the LSE, it sets the bar high for the biotechnology industry, contributing to the dynamic and diverse ecosystem of the LSEG. With its focus on cancer therapeutics, ValiRx is a key player in the healthcare sector, making strides in medical research and development.

UK 100

Latest directors dealings